Transcriptomic response to traffic-related air pollution during respiratory viral infection (TR[2]AP-RVI) in adults - seasonal respiratory viral infections (RVIS) are a major driver of morbidity and…

Active Grant Awarded

Award ID
RES039232UMF9Y8
Recipient
Awarding agency
Obligated
$666,229

Award facts

Completion date 1% complete
Place of performance
Rochester, NY 14611, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded Grant RES039232UMF9Y8, with $666,229 obligated, to the University of Rochester on November 13, 2026, under CFDA 93.ESR, Environmental Health Sciences - Research Projects. The award funds a study of how traffic-related air pollution (TRAP) affects immune response during respiratory viral infection (RVI) in adults. Recipient investigators will perform transcriptomic analysis on prospectively enrolled adults hospitalized for severe RVI and on non-infected orthopedic controls, across influenza, respiratory syncytial virus, and SARS-CoV-2. The project will build a high-resolution TRAP mixture model covering nitrogen dioxide, black carbon, total particle number concentration including ultrafine particles, and carbon monoxide, using a land use regression framework to estimate exposure at each participant's home address. Aim 1 applies a seasonal time-stratified case-crossover design to identify the weeks before hospitalization with the highest rate of RVI hospitalization associated with TRAP exposure. The study also characterizes exposure windows for wildfire smoke as a non-TRAP comparison. The working hypothesis is that acute TRAP exposure induces a maladaptive immune response in nasal mucosa and peripheral blood, increasing severe RVI risk and delaying recovery. Place of performance is Rochester, New York 14611. The award runs through its ultimate completion date of November 30, 2031.

Description

Transcriptomic response to traffic-related air pollution during respiratory viral infection (TR[2]AP-RVI) in adults - seasonal respiratory viral infections (RVIS) are a major driver of morbidity and mortality in the U.S. This proposal addresses a critical knowledge GAP in the mechanism of how short-term traffic-related air pollution (TRAP) exposures lead to immune dysfunction in adults hospitalized with RVI. Although model organism and human exposure studies have identified potential mechanisms by which air pollution predisposes to RVI, the critical windows of exposure for initial hospitalization risk and recovery remain uncharacterized. Furthermore, very little is known about how real-world exposure to air pollutant mixtures impacts anti-viral immunity. Our proposal will seek to overcome the limited depth present in many population epidemiology studies and the limited breadth of exposure studies by characterizing the critical windows of exposure of TRAP and non-TRAP (wildfire smoke) exposures, in three main RVI types (influenza, respiratory syncytial virus and sars-COV-2) in adults. We hypothesize that acute TRAP exposure induces a maladaptive immune response in both nasal mucosa and peripheral blood, increasing severe RVI risk and delaying recovery. We will perform transcriptomic analysis on prospectively enrolled adults hospitalized for severe RVI (and non-infected orthopedic controls). We will then generate a novel high-resolution TRAP mixture model (nitrogen dioxide [NO₂], black carbon [BC], total particle number concentration [including ultrafine particles] and carbon monoxide [CO]), using a land use regression framework to estimate pollution exposure at each participant's home address. In the first aim, we will use a novel seasonal time-stratified case-crossover design to determine the time windows in the weeks prior to hospitalization with the highest rate of RVI hospitalization associated with increased TRAP exposure. In the second aim we will study immune and inflammatory gene expression responses to TRAP exposure on admission in patients with RVI compared to non-infected controls. We will study both the nasal transcriptome (mucosal response) and peripheral blood transcriptome (systemic response). In the third aim we will focus on the effect of TRAP on symptomatic recovery from RVI by using serial measures of the flu-pro plus symptom survey. We will also gauge the effect of TRAP on immune recovery from RVI by performing transcriptomic analyses on serial mucosal and systemic samples (on admission and hospital discharge). The goal of this comprehensive study is to reveal actionable exposure windows for TRAP related public health alerts and personal mitigation strategies, inform targeted therapeutic and mechanistic research, and inform updates to national ambient air quality standards.

Quick answers

Who received award RES039232UMF9Y8?

RES039232UMF9Y8 was awarded to University Of Rochester by National Institute of Environmental Health Sciences (National Institutes of Health) on November 13, 2026.

How much is award RES039232UMF9Y8 worth?

$666,229 has been obligated on RES039232UMF9Y8.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award